Literature DB >> 15926647

QRS width and its impact on inducibility of ventricular arrhythmia at the time of electrophysiology study.

Mahi Lakshmi Ashwath1, Ike Okosun, Felix O Sogade.   

Abstract

The inducibility of sustained ventricular arrhythmia by programmed electrical stimulation is a well-established marker of an increased risk of ventricular tachyarrhythmia. The purpose of this investigation was to determine whether there was a significant difference in the QRS duration or ejection fraction (EF) amongst patients who could be induced and those who could not be induced into ventricular arrhythmia at the time of standard electrophysiology study (EPS). All the patients who were studied for inducibility of ventricular arrhythmias between March 2003 and March 2004 (a total of 137 patients) were included in the study. An EF less than or equal to 30% was used to define decreased EF, and a QRS width greater than 120 ms was used to define widened QRS width. Patients were studied using standard EPS protocol after obtaining informed consent. In the univariate analysis, increasing age, male gender and low EF were predictors of inducibility, while widened QRS width did not have any predictive value. With multivariate analysis, there was a significant increase in the odds of inducibility with decreasing EF and widened QRS width. Interestingly, males had significantly more numbers of positive results.

Entities:  

Mesh:

Year:  2005        PMID: 15926647      PMCID: PMC2569347     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  21 in total

Review 1.  Sudden death due to cardiac arrhythmias.

Authors:  H V Huikuri; A Castellanos; R J Myerburg
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  State-specific mortality from sudden cardiac death--United States, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-02-15       Impact factor: 17.586

Review 3.  Electrophysiology studies in patients with dilated cardiomyopathies.

Authors:  Henry H Hsia; Francis E Marchlinski
Journal:  Card Electrophysiol Rev       Date:  2002-12

4.  Electrical stimulation of the heart in patients with ventricular tachycardia.

Authors:  H J Wellens; R M Schuilenburg; D Durrer
Journal:  Circulation       Date:  1972-08       Impact factor: 29.690

Review 5.  The lungs as receptor sites for cardiovascular regulation.

Authors:  J T Shepherd
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

6.  Non-invasive detection of late potentials in man--a new marker for ventricular tachycardia.

Authors:  G Breithardt; R Becker; L Seipel; R R Abendroth; J Ostermeyer
Journal:  Eur Heart J       Date:  1981-02       Impact factor: 29.983

7.  Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction.

Authors:  M B Simson
Journal:  Circulation       Date:  1981-08       Impact factor: 29.690

8.  A blind comparison of four non-invasive twelve-lead electrocardiogram algorithms for predicting susceptibility to ventricular tachycardia.

Authors:  Todd J Cohen; Cindy Quan; Bassiema Ibrahim; Sincha Pollack; Weilun Quan
Journal:  J Invasive Cardiol       Date:  2002-09       Impact factor: 2.022

9.  Correlation between inducibility of sustained ventricular tachycardia and QRS duration.

Authors:  B Brembilla-Perrot
Journal:  Eur Heart J       Date:  1994-01       Impact factor: 29.983

10.  Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required.

Authors:  P Brugada; M Green; H Abdollah; H J Wellens
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

View more
  1 in total

1.  The relationship between electrocardiographic data and mortality in children diagnosed with dilated cardiomyopathy.

Authors:  Mehmet Türe; Hasan Balık; Alper Akın; Meki Bilici; Ahmet Nergiz
Journal:  Eur J Pediatr       Date:  2020-01-14       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.